Am J Transplant, Volume 16, Suppl 3 Archives - Page 149 of 180 - ATC Abstracts

2016 American Transplant Congress
Hepatitis C Patients in a Multicenter Study Who Received Living Donor Liver Transplants Are Likely to Have Increased Survival.
J. Kim,¹ K.-W. Lee,² G.-W. Song,³ B.-H. Jung,³ H. Lee,⁴ N.-J. Yi,² C. Kwon,¹ S. Hwang,³ K.-S. Suh,² J.-W. Joh,¹ S.-K. Lee,¹ S.-G. Lee.³
¹Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; ²Department of Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea; ³Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea; ⁴Department of Surgery, Seoul National University Boramae Medical Center, Seoul, Korea.
Background: No consensus has been reached regarding comparisons of outcomes for patients with hepatitis C virus (HCV) who received living donor liver transplantation (LDLT) versus…
2016 American Transplant Congress
NanoString Detection of Gene Signatures in Urine During Acute Cellular Rejection of Kidney Grafts.
K. Keslar,¹ A. Zmijewska,² J. Andriga,² K. Newell,³ R. Mannon,² P. Heeger,⁴ R. Fairchild.¹
¹Cleveland Clinic, Cleveland; ²UAB, Birmingham; ³Emory, Atlanta; ⁴MSSM, New York.
Considerable effort has focused on identification of gene expression patterns that may assist in diagnosis of acute cellular rejection. The NanoString platform offers a novel…
2016 American Transplant Congress
Acute Allograft Glomerulopathy: A Distinct Form of Cellular Rejection.
O. AL-Badri, M. Alexander, F. Cosio, L. Cornell.
Mayo Clinic, Rochester, MN.
Background: Acute allograft glomerulopathy (AAG) is an unusual glomerular lesion of allografts with endocapillary hypercellularity, markedly enlarged endothelial cells occluding the capillary lumen, and absence…
2016 American Transplant Congress
Elevated Lung Shunt Fraction as an Independent Predictor of Local Disease Progression and Metastasis in Hepatocellular Carcinoma.
T. Sandow,¹ D. DeVun,¹ P. Gulotta,¹ H. Bohorquez,² D. Kirsch.¹
¹Department of Radiology, Ochsner Clinic Foundation, New Orleans, LA; ²Department of Transplant Surgery, Ochsner Clinic Foundation, New Orleans, LA.
Purpose: To establish a relationship between lung shunt fraction (LSF) and local disease progression as well as the development of metastatic disease.Materials and Methods: A…
2016 American Transplant Congress
Impact of Sarcopenia in Overweight/Obese Recipients on the Outcomes After Adult Living Donor Liver Transplantation.
A. Hammad,^1,2 Y. Hamaguchi,² S. Okumura,² A. Kobayashi,² S. Yagi,² S. Uemoto,² T. Kaido.²
¹Department of Surgery, Mansoura University, Mansoura, Dakahliya, Egypt; ²Division of Hepato-Biliary-Pancreatic and Transplant Surgery Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Background/purpose: The effects of body composition disturbances on liver transplantation outcomes have recently been in focus. However, the effects of obesity, as well as sarcopenic…
2016 American Transplant Congress
Fatigue, Pain, and Other Physical Symptoms of Living Liver Donors.
Z. Butt,¹ A. DiMartini,² Q. Liu,³ M. Simpson,⁴ A. Smith,^3,5 J. Zee,³ B. Gillespie,⁵ S. Holtzman,⁶ D. Ladner,¹ K. Olthoff,⁷ R. Fisher,⁸ S. Hafliger,⁹ C. Freise,¹⁰ M. Mandell,¹¹ M. Dew.²
¹Northwestern U, Chicago; ²U of Pittsburgh, Pittsburgh; ³Arbor Research Collaborative for Health, Ann Arbor; ⁴Lahey, Burlington; ⁵U of Michigan, Ann Arbor; ⁶U of Toronto, Toronto, Canada; ⁷U of Pennslyvania, Philadelphia; ⁸Virginia Commonwealth U, Richmond; ⁹Columbia U, New York; ¹⁰U of California at San Francisco, San Francisco; ¹¹U of Colorado, Denver.
Background: Post-operative pain and fatigue can be significant for some living liver donors (LLD). A better appreciation of these outcomes may inform pre-donation education and…
2016 American Transplant Congress
Long Term Outcome of Kidney Transplant Recipients Treated with Everolimus: Final 5-Years Results from the Certic Observational Study.
L. Furian,¹ L. Di Maria,² G. Cappelli,³ M. Carmellini,⁴ G. Spagnoletti,⁵ G. Piredda,⁶ P. Todeschini,⁷ S. Chiaramonte,⁸ G. Tisone.⁹
¹AOU di Padova, Padova, Italy; ²AOU Careggi, Firenze, Italy; ³AOUP di Modena, Modena, Italy; ⁴AOU Senese, Siena, Italy; ⁵PU A.Gemelli, Roma, Italy; ⁶AO G.Brotzu, Cagliari, Italy; ⁷AOP S.Orsola-Malpighi, Bologna, Italy; ⁸PO S.Bortolo, Vicenza, Italy; ⁹Fondazione PU Tor Vergata, Roma, Italy.
Everolimus is associated with long-term benefits, such as preserving renal function and reducing the incidence of infections, malignancies and major cardiovascular events (MACE). The Certic…
2016 American Transplant Congress
Long-Term Deterioration of Graft Function (DeKAF) Study: Histologic Interpretation of Cross-sectional vs Prospective Cohorts.
A. Matas,¹ A. Fieberg,¹ L. Hunsicker,² J. Grande,³ For the DeKAF Group.
¹U of MN, Mpls, MN; ²U IA, Iowa City, IA; ³Mayo, Rochester, MN.
The major aim of the DeKAF study was to define previously unidentified phenotypes resulting in late graft dysfunction and loss (GL). Two cohorts were developed,…
2016 American Transplant Congress
Complex Constellation of HLA Antibodies Contributes to Decreasing Trend of Transplant Rate in Candidates with 100% CPRA.
R. Rajalingam, D. Hyon Gae, D. Kopchaliiska, O. Buenaventura, K. Cunniffe, G. Da Gente, J. Roberts.
Immunogenetics and Transplantation Laboratory; Department of Surgery, University of California-San Francisco, San Francisco, CA.
The key component of new KAS is offering an increased priority for sensitized candidates. While transplants (tx) have increased six-fold for recipients with a CPRA…
2016 American Transplant Congress
A Selective Biomarker in Blood Cells Identifies IFTA After Kidney Transplantation.
M. Matz,¹ C. Lorkowski,¹ K. Wu,³ H.-H. Neumayer,¹ M.-F. Mashreghi,² K. Budde.¹
¹Nephrology, University Charité, Berlin, Germany; ²German Rheumatism Research Center (DRFZ), Berlin, Germany; ³Pathology, University Medicine Charité, Berlin, Germany.
Cellular and antibody-mediated rejection processes and also interstitial fibrosis/tubular atrophy (IFTA) lead to allograft dysfunction and loss. The search for accurate and specific diagnostic tools…